CDDO-Me
Bardoxolone Methyl (TP-155) is a synthetic triterpenoid that activates the Nrf2 antioxidant pathway while inhibiting the pro-inflammatory NF-κB pathway. It has demonstrated anti-inflammatory and potential anti-tumor activity in various in vitro and in vivo research models, including studies on kidney disease and cancer.
Product Specifications
CAS Number
218600-53-4
Product Name Alternative
Bardoxolone methyl; RTA 402; TP-155; CDDO-Methyl ester
Field of Research
Cancer Biology, Cell Biology
Purity
>98%
Form
Powder
Solubility
Soluble in DMSO (25 mg/ml, warm)
Smiles
[H][C@@]12CC (C) (C) CC[C@@]1 (CC[C@]1 (C) C2C (=O) C=C2[C@@]1 (C) CC[C@@]1 ([H]) C (C) (C) C (=O) C (=C[C@]21C) C#N) C (=O) OC
Molecular Formula
C32H43NO4
Molecular Weight
505.7
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
2-Cyano-3,12-dioxooleana-1,9 (11) -dien-28-oic acid methyl ester
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog